Non-Invasive Blood Glucose Monitoring Devices Market Future and Technological Advancement To 2026 With Key Vendors Abbott Laboratories, F. Hoffmann-La Roche Ltd., Integrity Applications Inc., Bayer Healthcare, Pendragon Medical

Non-invasive blood glucose monitoring devices measures blood glucose levels in patients suffering from diabetes, without puncturing the skin, or causing pain or trauma. The frequent change in blood glucose levels in diabetic patients has to be tracked by the glucose monitoring device. Glucose monitoring devices can be invasive or non-invasive but the non-invasive blood glucose monitoring devices market is increasing due to the need of an economic, compact, painless and convenience for the patients to use. Non-invasive glucose monitoring holds great promise for improving diabetes management by providing better and pain-free blood glucose measurement leading to expansion of non-invasive blood glucose monitor market in the forecast period.

Download PDF Brochure of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-pdf/1480

Non-Invasive Blood Glucose Monitoring Devices Market Driver

The global non-invasive blood glucose monitoring devices market is expected to be boosted by the increasing diabetes prevalence. According to World Health Organisation (WHO), in 2014, diabetes mellitus is a worldwide epidemic disease affecting 422 million people and seventh leading cause of death in US. The glucose concentration of diabetic patients fluctuates significantly throughout the day which can lead to serious consequences like kidney failure, strokes, heart attacks, high blood pressure, blindness and coma. These demand the technologically advanced devices for frequent monitoring of blood glucose levels.

Moreover, the invasive techniques of blood glucose monitor are painful and expensive as compared to non-invasive blood glucose monitoring device, this makes non-invasive blood glucose monitoring device as the device of choice amongst the patients. Furthermore, the high percentage of prediabetes patients, a condition were blood glucose levels are high but not sufficient to detect the diabetes, will also propel the non-invasive blood glucose monitoring device market in the forecast period. According to NIDDK, in 2015, 33.9% of US adults are estimated to be prediabetes, at increased risk of developing type 2 diabetes.

Traditional glucose detection device based on electrochemical sensors which requires a small amount of blood sample by finger pricking makes the method inconvenient and painful, which demanded emergence of non-invasive blood glucose monitor device. Currently, non-invasive blood glucose monitors are under great technological advancement to overcome this challenges in currently available glucose monitor. For instance, in March 2018, Nemaura Medical Inc. developing the wireless sugarBEAT, a non-invasive blood glucose monitoring system, received positive results from European clinical trial program which makes a significant milestone towards commercialization of sugarBEAT in the UK, followed by other territories upon achieving CE approval.

Non-Invasive Blood Glucose Monitoring Devices Market - Competitors

The major players for non-invasive blood glucose monitoring device market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Integrity Applications, Inc., Bayer Healthcare, Pendragon Medical, Animas Technologies, Omron and OrSense.

Request For Customization Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-customization/1480

Non-Invasive Blood Glucose Monitoring Devices Market Taxonomy:

By Technology:
Bio-impedance spectroscopy
Electromagnetic sensing
Fluorescence
Mid-infrared / Near infrared spectroscopy
Optical coherence tomography
Optical polarimetry
Raman spectroscopy
Reverse iontophoresis
Ultrasound technology

By Modality:
Wearable
Non-wearable / table top

By End Users
Hospitals & Clinics
Diagnostic centers
Homecare setting

Non-Invasive Blood Glucose Monitoring Devices- Regional Analysis

On the basis of region, the global non-invasive blood glucose monitoring device market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be dominant region with respect to non-invasive blood glucose monitoring device market due to high prevalence of disease in geriatric population which is 25.2 % in US population as per American Diabetes Association of year 2015.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.